metricas
covid
Enfermedades Infecciosas y Microbiología Clínica (English Edition) Cost-effectiveness of cabotegravir versus tenofovir alafenamide plus emtricitabi...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Cost-effectiveness of cabotegravir versus tenofovir alafenamide plus emtricitabine versus tenofovir disoproxil fumarate plus emtricitabine for pre-exposure prophylaxis to prevent HIV-1 transmission in gay, bisexual and other men that have sex with men
Coste-efectividad de cabotegravir versus tenofovir alafenamida con emtricitabina versus tenofovir disoproxil fumarato con emtricitabina para la profilaxis preexposición de la transmisión del VIH-1 en gais, bisexuales u otros hombres que tienen sexo con hombres
Philip Erick Wikman-Jorgensena,b,
Corresponding author
pwikman@umh.es

Corresponding author.
, Marta Ruiz-Algueróc,e, Carlos Iniestad,e, Federico Pulidoe,f, Jara Llenas-Garcíab,e,g
a Internal Medicine & Infectious Diseases Department, Elda General University Hospital-FISABIO, Elda, Spain
b Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain
c Faculty of Medicine, University of British Columbia, Vancouver, Canada
d Spanish Interdisciplinary AIDS Society (SEISIDA), Madrid, Spain
e Centre of Biomedical Research for Infectious Diseases (CIBERINFEC), Madrid, Spain
f HIV Unit, Institute for Healthcare Research Hospital 12 de Octubre (imas12), Universidad Complutense de Madrid, Madrid, Spain
g Infectious Diseases-Internal Medicine Department, Hospital Vega Baja-FISABIO, Orihuela, Spain
Read
Not available
Times
was read the article
Total PDF
Total HTML
Share statistics
Article information
ISSN: 2529993X
Original language: English
The statistics are updated each day

Follow this link to access the full text of the article